Robert J. Holt

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Raymond S. Douglas, George J. Kahaly, Amy Patel et al. · New England Journal of Medicine · 2020 · 700 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +11

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue

Richard D. Kennedy, Max Bylesjö, Peter Kerr et al. · Journal of Clinical Oncology · 2011 · 190 citations

Medicine, Oncology, Pathology +17

Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials

George J. Kahaly, Raymond S. Douglas, Robert J. Holt et al. · The Lancet Diabetes & Endocrinology · 2021 · 179 citations

Medicine, Endocrinology, Ophthalmology +10

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Raymond S. Douglas, George J. Kahaly, Shoaib Ugradar et al. · Ophthalmology · 2021 · 158 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13

Invariant Signatures for Planar Shape Recognition under Partial Occlusion

Alfred M. Bruckstein⋆, Robert J. Holt, Arun N. Netravali et al. · CVGIP Image Understanding · 1993 · 87 citations

Computing, Computer Science, Computational Geometry +15